RA

Royce & Associates Portfolio holdings

AUM $12.4B Turnover 20.64%
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+28.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$12.4B
AUM Growth
+$2.29B
Cap. Flow
-$8.07M
Cap. Flow %
-0.07%
Top 10 Hldgs %
9.07%
Holding
848
New
74
Increased
361
Reduced
233
Closed
101
Avg Time Held
4.5 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
1.8 years

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$43.3M
2
MSA icon
Mine Safety
MSA
+$37.1M
3
YSWY icon
Yesway Inc
YSWY
+$34.7M
4
DORM icon
Dorman Products
DORM
+$24.6M
5
AVTR icon
Avantor
AVTR
+$19M

Top Sells

Rank Stock Value
1
COHU icon
Cohu
COHU
+$54.5M
2
CPRX icon
Catalyst Pharmaceutical
CPRX
+$51.1M
3
MKSI icon
MKS Inc
MKSI
+$44.5M
4
VSH icon
Vishay Intertechnology
VSH
+$40.2M
5
LFUS icon
Littelfuse
LFUS
+$35.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.88%
2 Technology 19.45%
3 Financials 14.84%
4 Consumer Discretionary 12.86%
5 Healthcare 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WU icon
551
Western Union
WU
$1.89B
$3.38M 0.03%
439,002
+372,365
+559% +$3.12M
2025 Q3
3 quarters
AXGN icon
552
Axogen
AXGN
$2.06B
$3.35M 0.03%
72,516
-41,013
-36% -$1.65M
2025 Q3
3 quarters
CAE icon
553
CAE Inc
CAE
$7.48B
$3.33M 0.03%
133,079
-64,738
-33% -$1.68M
2025 Q2
4 quarters
PHIN icon
554
Phinia Inc
PHIN
$2.05B
$3.31M 0.03%
40,124
-775
-2% -$59.3K
2024 Q3
7 quarters
RGLD icon
555
Royal Gold
RGLD
$19.1B
$3.14M 0.03%
15,718
-6,320
-29% -$1.47M
2013 Q3
51 quarters
CENT icon
556
Central Garden & Pet Co
CENT
$2.59B
$3.11M 0.03%
70,196
+3,361
+5% +$132K
2023 Q4
10 quarters
BHE icon
557
Benchmark Electronics
BHE
$2.67B
$3.1M 0.03%
31,442
-6,098
-16% -$486K
2013 Q2
52 quarters
ALKS icon
558
Alkermes
ALKS
$6.56B
$3.04M 0.02%
58,072
+2,389
+4% +$93.3K
2024 Q1
9 quarters
HCI icon
559
HCI Group
HCI
$2.44B
$3.01M 0.02%
17,190
+6,715
+64% +$1.06M
2024 Q3
7 quarters
CELC icon
560
Celcuity
CELC
$2.93B
$3.01M 0.02%
+28,749
New +$3.32M
2026 Q2
0 quarters
PRG icon
561
PROG Holdings
PRG
$1.19B
$3M 0.02%
64,392
+3,918
+6% +$137K
2023 Q4
10 quarters
CVGI icon
562
Commercial Vehicle Group
CVGI
$113M
$2.96M 0.02%
+640,175
New +$3M
2026 Q2
0 quarters
BBOT icon
563
BridgeBio Oncology
BBOT
$233M
$2.93M 0.02%
384,941
-251,581
-40% -$2.1M
2026 Q1
1 quarter
CMPX icon
564
Compass Therapeutics
CMPX
$158M
$2.93M 0.02%
1,336,780
-283,018
-17% -$836K
2025 Q4
2 quarters
PGNY icon
565
Progyny
PGNY
$2.14B
$2.88M 0.02%
99,819
+40,456
+68% +$904K
2024 Q4
6 quarters
OTTR icon
566
Otter Tail
OTTR
$3.75B
$2.85M 0.02%
31,715
+180
+0.6% +$15.9K
2023 Q2
12 quarters
SKYW icon
567
Skywest
SKYW
$3.59B
$2.84M 0.02%
28,580
+8,927
+45% +$795K
2024 Q2
8 quarters
SMRT icon
568
SmartRent
SMRT
$222M
$2.82M 0.02%
2,369,571
-255,000
-10% -$324K
2023 Q2
12 quarters
SPNT icon
569
SiriusPoint
SPNT
$2.94B
$2.76M 0.02%
114,805
+80,265
+232% +$1.84M
2024 Q1
9 quarters
SMPL icon
570
Simply Good Foods
SMPL
$948M
$2.74M 0.02%
206,485
+159,042
+335% +$1.96M
2025 Q4
2 quarters
AWR icon
571
American States Water
AWR
$3.27B
$2.7M 0.02%
32,654
+28,267
+644% +$2.19M
2026 Q1
1 quarter
PFBC icon
572
Preferred Bank
PFBC
$1.21B
$2.67M 0.02%
25,156
+166
+0.7% +$15.9K
2019 Q1
29 quarters
ATEC icon
573
Alphatec Holdings
ATEC
$1.61B
$2.65M 0.02%
306,066
+65,013
+27% +$592K
2018 Q3
31 quarters
LFMD icon
574
LifeMD
LFMD
$114M
$2.63M 0.02%
636,124
-565,527
-47% -$2.5M
2022 Q2
16 quarters
IRDM icon
575
Iridium Communications
IRDM
$4.85B
$2.62M 0.02%
47,744
+26,832
+128% +$1.15M
2026 Q1
1 quarter

Similar funds

Royce & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Royce & Associates held 848 positions worth $12.4B, up 23% from $10.1B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Royce & Associates's Q2 2026 filing shows 74 new, 361 increased, 233 reduced and 101 closed positions. Its largest new stake was Manhattan Associates: 314,304 shares worth $43.8M. The largest sale was Cohu, an estimated $54.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2026 buy was Manhattan Associates: 314,304 shares worth $43.8M.
  • Royce & Associates added most to Mine Safety in Q2 2026, an estimated $37.1M increase.
  • Royce & Associates's biggest Q2 2026 reduction was Cohu, cutting an estimated $54.5M.
  • Royce & Associates fully exited Transmedics in Q2 2026, selling an estimated $24.3M.
  • Royce & Associates's ten largest holdings make up 9.1% of its $12.4B portfolio in Q2 2026.
  • Royce & Associates opened 74 new positions and closed 101 in Q2 2026.
  • Royce & Associates's portfolio value rose 23% quarter-over-quarter to $12.4B.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.